Want to see FR:NRO full AI Analyst Report?
Total Valuation
Neurones has a market cap or net worth of €879.48M. The enterprise value is €631.41.
Market Cap€879.48M
Enterprise Value€631.41
Share Statistics
Neurones has 24,328,716 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,328,716
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neurones’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.62%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.62%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee118.92K
Profits Per Employee7.22K
Employee Count7,208
Asset Turnover1.14
Inventory Turnover42.62K
Valuation Ratios
The current PE Ratio of Neurones is 15.7. Neurones’s PEG ratio is -14.55.
PE Ratio15.7
PS Ratio1.45
PB Ratio3.11
Price to Fair Value3.11
Price to FCF17.69
Price to Operating Cash Flow10.43
PEG Ratio-14.55
Income Statement
In the last 12 months, Neurones had revenue of 857.20M and earned 52.07M in profits. Earnings per share was 2.14.
Revenue857.20M
Gross Profit90.04M
Operating Income72.33M
Pretax Income82.60M
Net Income52.07M
EBITDA90.32M
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 100.76M and capital expenditures -12.18M, giving a free cash flow of 88.59M billion.
Operating Cash Flow100.76M
Free Cash Flow88.59M
Free Cash Flow per Share3.64
Dividends & Yields
Neurones pays an annual dividend of €1.4, resulting in a dividend yield of 3.91%
Dividend Per Share€1.4
Dividend Yield3.91%
Payout Ratio61.37%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-4.24%
50-Day Moving Average37.18
200-Day Moving Average36.43
Relative Strength Index (RSI)44.34
Average Volume (3m)5.27K
Important Dates
Neurones upcoming earnings date is Mar 10, 2027, TBA (Confirmed).
Last Earnings DateSep 9, 2026
Next Earnings DateMar 10, 2027
Ex-Dividend Date―
Financial Position
Neurones as a current ratio of 2.43, with Debt / Equity ratio of 10.98%
Current Ratio2.43
Quick Ratio2.43
Debt to Market Cap<0.01
Net Debt to EBITDA-3.36
Interest Coverage Ratio60.43
Taxes
In the past 12 months, Neurones has paid 20.75M in taxes.
Income Tax20.75M
Effective Tax Rate0.25
Enterprise Valuation
Neurones EV to EBITDA ratio is 10.41, with an EV/FCF ratio of 13.37.
EV to Sales1.10
EV to EBITDA10.41
EV to Free Cash Flow13.37
EV to Operating Cash Flow11.64
Balance Sheet
Neurones has €301.88M in cash and marketable securities with €41.30M in debt, giving a net cash position of €260.58M billion.
Cash & Marketable Securities€301.88M
Total Debt€41.30M
Net Cash€260.58M
Net Cash Per Share€10.71
Tangible Book Value Per Share€13.91
Margins
Gross margin is 56.88%, with operating margin of 8.44%, and net profit margin of 6.07%.
Gross Margin56.88%
Operating Margin8.44%
Pretax Margin9.64%
Net Profit Margin6.07%
EBITDA Margin10.54%
EBIT Margin8.44%
Analyst Forecast
The average price target for Neurones is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.68%
EPS Growth Forecast9.16%